-

Grant & Eisenhofer Files Class Action Lawsuit Against Citadel Securities LLC and Virtu Americas LLC

NEW YORK--(BUSINESS WIRE)--On November 14, 2025, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of Genius Group Limited (“Genius”) against Citadel Securities LLC (“Citadel”) and Virtu Americas LLC (“Virtu”) (together, the “Defendants”). The action alleges that Defendants defrauded investors by placing and executing manipulative trades designed to artificially deflate the price of Genius stock.

The lawsuit alleges that throughout the Class Period, Defendants engaged in a manipulative and illegal trading practice known as “spoofing,” which involves submitting and then cancelling buy or sell orders without any genuine intent to execute them.

Share

The action is brought on behalf of all persons who sold securities of Genius between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”). The action, brought in the United States District Court for the Southern District of New York, is captioned Genius Group Limited v. Citadel Securities LLC, and Virtu Americas LLC, No. 1:25-cv-09546 (S.D.N.Y.).

Citadel and Virtu are broker-dealers registered with the Securities and Exchange Commission and operate as major market makers, routinely placing and executing securities trades for investors as well as for their own trading accounts.

The complaint alleges violations of Sections 9(a) and 10(b) of the Securities Exchange Act of 1934. Specifically, the lawsuit alleges that throughout the Class Period, Defendants engaged in a manipulative and illegal trading practice known as “spoofing,” which involves submitting and then cancelling buy or sell orders without any genuine intent to execute them. The purpose of these “baiting orders” was to mislead other market participants about the true level of supply and demand for Genius securities, or about the stock’s price volatility, thereby influencing the market price of Genius to benefit Defendants’ own trading positions. Defendants entered thousands of these baiting orders on U.S. stock exchanges to create the false impression that Genius’ stock price reflected genuine supply-and-demand and volatility dynamics, while simultaneously profiting by absorbing and reselling their customers’ order flow at prices favorable to Defendants.

Throughout the Class Period, sharp declines in Genius’ stock price consistently coincided with substantial spikes in Defendants’ spoofing activity. For example, during the week of February 10, 2025, Defendants built significant short positions in Genius stock and reaped substantial trading profits: Citadel traded more than 23 million shares of Genius off-exchange, accounting for nearly half of all off-exchange trading in the stock, while Virtu traded nearly 11 million shares, accounting for more than 20% of all off-exchange trading. Together, Defendants comprised nearly 70% of all off-exchange trading in Genius stock that week, as short volume surged from a low of 53% to more than 61%. As a result, Genius’ stock price decline by 22% despite the absence of any new material, company-specific news.

Investors who sold Genius securities during the Class Period are members of this proposed Class and may be able to seek appointment as lead plaintiff, which is a court-appointed representative of the Class, by complying with the relevant provisions of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). See 15 U.S.C. Section 78u-4(a)(2)(A)(i)-(vi).

If you wish to serve as lead plaintiff, you must move the Court by no later than January 16, 2026. You do not need to seek to become a lead plaintiff in order to share in any possible recovery. You may also retain counsel of your choice to represent you in this action.

If you wish to discuss this action or have any questions concerning this notice or your rights, please contact Abe Alexander at Grant & Eisenhofer at 646-722-8500, or via email at aalexander@gelaw.com.

Contacts

Abe Alexander
Grant & Eisenhofer P.A.
Tel.: (646) 722-8500
aalexander@gelaw.com

Grant & Eisenhofer P.A.


Release Versions

Contacts

Abe Alexander
Grant & Eisenhofer P.A.
Tel.: (646) 722-8500
aalexander@gelaw.com

More News From Grant & Eisenhofer P.A.

Grant & Eisenhofer Files Class Action Lawsuit Against Primo Brands Corp.

NEW YORK--(BUSINESS WIRE)--Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of Stuart Rosenblum against Primo Brands Corporation (“Primo Brands” or the “Company”) and three of the Company’s senior executives and directors, including CFO David Hass, Director C. Dean Metropoulos, and former CEO Robbert Rietbroek (collectively, the “Defendants”). The action alleges that Defendants defrauded investors by making materially false and/or misleading statements and by failing to...

Grant & Eisenhofer Files Class Action Lawsuit Against Inspire Medical Systems, Inc.

NEW YORK--(BUSINESS WIRE)--Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of City of Pontiac Reestablished General Employees’ Retirement System against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) and three of the Company’s senior executives, including CEO Timothy Herbert, CFO Richard Buchholz, and Chief Strategy and Growth Officer Carlton Weatherby (collectively, the “Defendants”). The action alleges that Defendants defrauded investors by making...

Grant & Eisenhofer Files Class Action Lawsuit Against Neogen Corporation

NEW YORK--(BUSINESS WIRE)--Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of Operating Engineers Construction Industry and Miscellaneous Pension Fund against Neogen Corporation (“Neogen” or the “Company”), Neogen’s CEO John Adent, and Neogen’s COO & CFO David Naemura (collectively, the “Defendants”). The action alleges that Defendants defrauded investors by making materially false and/or misleading statements and failing to disclose materially adverse facts about...
Back to Newsroom